Trial · NCT04654468
Adverse events25
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 25
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | CROVALIMAB | 7 | 51 | 8 |
| other | Gingival swelling | Gastrointestinal disorders | CROVALIMAB | 3 | 51 | 3 |
| other | Upper respiratory tract infection | Infections and infestations | CROVALIMAB | 24 | 51 | 26 |
| other | Urinary tract infection | Infections and infestations | CROVALIMAB | 3 | 51 | 4 |
| other | Alanine aminotransferase increased | Investigations | CROVALIMAB | 11 | 51 | 15 |
| other | Alpha hydroxybutyrate dehydrogenase increased | Investigations | CROVALIMAB | 8 | 51 | 8 |
| other | Bilirubin conjugated increased | Investigations | CROVALIMAB | 15 | 51 | 27 |
| other | Blood alkaline phosphatase increased | Investigations | CROVALIMAB | 9 | 51 | 12 |
| other | Blood bilirubin increased | Investigations | CROVALIMAB | 9 | 51 | 10 |
| other | Blood bilirubin unconjugated increased | Investigations | CROVALIMAB | 12 | 51 | 13 |
| other | Gamma-glutamyltransferase increased | Investigations | CROVALIMAB | 6 | 51 | 9 |
| other | Lymphocyte count decreased | Investigations | CROVALIMAB | 8 | 51 | 15 |
| other | Neutrophil count decreased | Investigations | CROVALIMAB | 13 | 51 | 25 |
| other | Platelet count decreased | Investigations | CROVALIMAB | 5 | 51 | 10 |
| other | Weight increased | Investigations | CROVALIMAB | 6 | 51 | 6 |
| other | White blood cell count decreased | Investigations | CROVALIMAB | 12 | 51 | 29 |
| other | Hypercholesterolaemia | Metabolism and nutrition disorders | CROVALIMAB | 3 | 51 | 5 |
| other | Hypertriglyceridaemia | Metabolism and nutrition disorders | CROVALIMAB | 5 | 51 | 16 |
| other | Hyperuricaemia | Metabolism and nutrition disorders | CROVALIMAB | 5 | 51 | 7 |
| serious | Thrombocytopenia | Blood and lymphatic system disorders | CROVALIMAB | 1 | 51 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04654468/events